IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 106 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $13,000 | -7.1% | 10,200 | +32.5% | 0.01% | 0.0% |
Q1 2018 | $14,000 | -6.7% | 7,700 | +6.9% | 0.01% | -14.3% |
Q4 2017 | $15,000 | +200.0% | 7,200 | +200.0% | 0.01% | +250.0% |
Q3 2017 | $5,000 | -28.6% | 2,400 | -41.5% | 0.00% | -50.0% |
Q2 2017 | $7,000 | -22.2% | 4,100 | +13.9% | 0.00% | -20.0% |
Q1 2017 | $9,000 | +80.0% | 3,600 | 0.0% | 0.01% | +66.7% |
Q4 2016 | $5,000 | -58.3% | 3,600 | -25.0% | 0.00% | -57.1% |
Q3 2016 | $12,000 | +71.4% | 4,800 | -2.0% | 0.01% | +75.0% |
Q2 2016 | $7,000 | -30.0% | 4,900 | 0.0% | 0.00% | -33.3% |
Q1 2016 | $10,000 | -33.3% | 4,900 | 0.0% | 0.01% | -25.0% |
Q4 2015 | $15,000 | -6.2% | 4,900 | 0.0% | 0.01% | -20.0% |
Q3 2015 | $16,000 | -5.9% | 4,900 | +6.5% | 0.01% | 0.0% |
Q2 2015 | $17,000 | +13.3% | 4,600 | +12.2% | 0.01% | +11.1% |
Q1 2015 | $15,000 | – | 4,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 5,663,845 | $21,013,000 | 1.13% |
HealthCor Management, L.P. | 1,335,000 | $4,953,000 | 0.25% |
Baker Brothers Advisors | 6,970,902 | $25,862,000 | 0.23% |
Palo Alto Investors LP | 1,226,748 | $4,551,000 | 0.20% |
WALL STREET ASSOCIATES | 500,000 | $1,855,000 | 0.18% |
NATIXIS | 3,148,916 | $11,682,000 | 0.16% |
MYCIO WEALTH PARTNERS, LLC | 200,000 | $742,000 | 0.14% |
GUARDIAN LIFE INSURANCE CO OF AMERICA | 371,759 | $1,379,000 | 0.12% |
HOLLENCREST CAPITAL MANAGEMENT | 177,570 | $659,000 | 0.10% |
CARL DOMINO INC | 32,137 | $119,000 | 0.08% |